MHAUS sponsors one-day conference on Malignant Hyperthermia

Medical professionals, patients and families can learn the basics on how recognize, diagnose, and treat Malignant Hyperthermia at a one-day Malignant Hyperthermia conference happening from 10 am to 4 pm June 25 at Lake Receptions located in Mt. Dora, Florida.

Malignant Hyperthermia (MH) is an inherited muscle disorder triggered by certain types of anesthesia that may cause a fast-acting life-threatening crisis. The incidence of MH is low, but, if untreated, the mortality rate is high. Great advances in our understanding of MH have been made since it was first recognized in the early 1960s, but the nature of the fundamental defect(s) is still unknown.

To see video about the conference and to register go to: http://www.mhaus.org or for details contact MHAUS by email at: [email protected] or by phone at: 607-674-7901

Conference is sponsored by the Malignant Hyperthermia Association of the United States and it held in memory of Vincent Groetzner June 27, 2003 - June 14, 2010.

Upon completion participants will be able to: 1) Identify the signs and symptoms of an MH event. 2) Enforce quick treatment regimen for MH event. 3) Explain the response plant for an MH event to other medical staff. 4) State proper patient safety steps to take in preparation for an MH-susceptible patient. 5) Discuss MH testing options with patients and assist them in seeking further information. There are four education credits available.

CONFERENCE SPEAKERS
Mary Theroux, MD, Anesthesiologist at Alfred I. DuPont Hospital for Children, Wilmington DE, and MHAUS Hotline Consultant

Deanna P. Steele, MS, CGC, Genetics Counselor at Magee-Womens Hospital, Pittsburgh, P.A.

Andrew Herlich, MD, Anesthesiologist at University of Pennsylvania Medical Center Pittsburgh, P.A., and MHAUS Hotline Consultant